Malignant Neoplasm of Stomach Active Not Recruiting Phase 2 Trials for Cisplatin (DB00515)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00911820Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric CancerTreatment
NCT02891447Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal CancerTreatment
NCT03382600Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659)Treatment
NCT01412294XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric CancerTreatment
NCT01406249XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric CancerTreatment
NCT00674167The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus AdenocarcinomaTreatment
NCT01228045A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric CancerTreatment